Transplantation with autologous hematopoietic. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy28

T-Lymphocytes Hematopoietic Stem Cells Transplants Cells, Cultured Antilymphocyte Serum Bone Marrow Cells Bone Marrow Stem Cells T-Lymphocytes, Cytotoxic Liver Lymphocytes Dendritic Cells Portal Vein Mesenchymal Stromal Cells Fetal Blood CD4-Positive T-Lymphocytes Killer Cells, Natural Clone Cells CD8-Positive T-Lymphocytes Kidney T-Lymphocytes, Regulatory Leukocytes, Mononuclear Autografts Amnion B-Lymphocytes Spleen Myoblasts, Skeletal Hepatic Artery

Organisms8

Transplantation Chimera Mice, Inbred C57BL Rats, Inbred Lew Mice, SCID Mice, Inbred BALB C Chimera Radiation Chimera Cytomegalovirus

Diseases47

Graft vs Host Disease Recurrence Liver Failure Postoperative Complications Hematologic Neoplasms Multiple Myeloma Lymphoma, Non-Hodgkin Cadaver Leukemia Liver Diseases Hodgkin Disease Acute Disease Leukemia, Myeloid, Acute Kidney Failure, Chronic Anemia, Aplastic Cytomegalovirus Infections Bronchiolitis Obliterans Blood Group Incompatibility Precursor Cell Lymphoblastic Leukemia-Lymphoma Disease Models, Animal Lymphoma End Stage Liver Disease Infection Myelodysplastic Syndromes Leukemia, Myeloid Hematologic Diseases Brain Death Hepatic Veno-Occlusive Disease Liver Failure, Acute Liver Cirrhosis Lymphoproliferative Disorders Leukemia, Myelogenous, Chronic, BCR-ABL Positive Primary Graft Dysfunction Delayed Graft Function Liver Neoplasms Biliary Atresia Neoplasms Chronic Disease Severe Combined Immunodeficiency Carcinoma, Hepatocellular Corneal Diseases Opportunistic Infections Neoplasm, Residual Ischemia Reperfusion Injury Melanoma Kidney Diseases

Chemicals and Drugs36

Immunosuppressive Agents Melphalan Cyclophosphamide Busulfan Cyclosporine Tacrolimus HLA Antigens Carmustine Myeloablative Agonists Antigens, CD34 Antilymphocyte Serum Etoposide Granulocyte Colony-Stimulating Factor Cytarabine Antibodies, Monoclonal Thiotepa Mycophenolic Acid Prednisone Antigens, Neoplasm Vincristine ABO Blood-Group System Antigens, CD Vidarabine Isoantibodies Isoantigens Interleukin-2 Antibodies, Neoplasm Cancer Vaccines Azathioprine Antineoplastic Agents, Alkylating Biological Markers Antineoplastic Agents Organ Preservation Solutions Cyclosporins Interferon-gamma Recombinant Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment107

Transplantation, Autologous Liver Transplantation Transplantation, Homologous Bone Marrow Transplantation Kidney Transplantation Hematopoietic Stem Cell Transplantation Heart Transplantation Stem Cell Transplantation Lung Transplantation Transplantation Conditioning Organ Transplantation Blood Transfusion, Autologous Cell Transplantation Pancreas Transplantation Islets of Langerhans Transplantation Transplantation Treatment Outcome Peripheral Blood Stem Cell Transplantation Transplantation, Isogeneic Transplantation, Heterotopic Cord Blood Stem Cell Transplantation Heart-Lung Transplantation Retrospective Studies Combined Modality Therapy Immunosuppression Histocompatibility Testing Whole-Body Irradiation Skin Transplantation Fetal Tissue Transplantation Mesenchymal Stem Cell Transplantation Follow-Up Studies Survival Analysis Transplantation, Heterologous Tissue Transplantation Survival Rate Remission Induction Corneal Transplantation Antineoplastic Combined Chemotherapy Protocols Bone Marrow Purging Disease-Free Survival Hematopoietic Stem Cell Mobilization Brain Tissue Transplantation Salvage Therapy Facial Transplantation Organ Preservation Donor Selection Prognosis Lymphocyte Culture Test, Mixed Risk Factors Tissue and Organ Harvesting Prospective Studies Lymphocyte Activation Postoperative Period Actuarial Analysis Cell Separation Flow Cytometry Lymphocyte Transfusion Hand Transplantation Patient Selection Neoplasm Transplantation Lymphocyte Depletion Disease Models, Animal Feasibility Studies Bone Transplantation Immunotherapy, Adoptive Leukapheresis Biopsy Models, Animal Fatal Outcome Blood Transfusion Cell Culture Techniques Anastomosis, Surgical Immunotherapy Immunophenotyping Multivariate Analysis Kaplan-Meier Estimate Incidence Cryopreservation Postoperative Care Reoperation Leukocyte Count Cell- and Tissue-Based Therapy Cold Ischemia Blood Component Removal Colony-Forming Units Assay Tissue Engineering Hepatectomy Platelet Count Coculture Techniques Platelet Transfusion Tissue Preservation Immunohistochemistry Leukocyte Transfusion Genetic Therapy Blood Cell Count Preoperative Care Cohort Studies Graft Enhancement, Immunologic Risk Assessment Heart-Assist Devices Pilot Projects Cytotoxicity Tests, Immunologic Polymerase Chain Reaction Severity of Illness Index Proportional Hazards Models Transduction, Genetic Life Tables

Psychiatry and Psychology1

Phenomena and Processes25

Graft Survival Graft Rejection Transplantation Immunology Time Factors Transplantation Tolerance Histocompatibility Cytotoxicity, Immunologic Cell Differentiation Lymphocyte Activation Hematopoiesis Graft vs Tumor Effect Chimerism Graft vs Leukemia Effect Immune Tolerance Regeneration Leukocyte Count Platelet Count Graft vs Host Reaction Blood Cell Count Cell Survival Cell Proliferation Immunocompromised Host Radiation Chimera Recovery of Function Transduction, Genetic

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

Technology, Industry, Agriculture1

Tissue Engineering

Information Science4

Survival Rate Fatal Outcome Incidence Life Tables

Named Groups4

Tissue Donors Living Donors Siblings Unrelated Donors

Health Care29

Treatment Outcome Retrospective Studies Tissue and Organ Procurement Follow-Up Studies Survival Analysis Survival Rate Waiting Lists Disease-Free Survival Donor Selection Risk Factors Prospective Studies Postoperative Period Actuarial Analysis Patient Selection Feasibility Studies Fatal Outcome Multivariate Analysis Kaplan-Meier Estimate Incidence Postoperative Care Preoperative Care Cohort Studies Risk Assessment Directed Tissue Donation Pilot Projects Age Factors Severity of Illness Index Proportional Hazards Models Life Tables

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Named Groups Health Care

Transplantation, Autologous Liver Transplantation Transplantation, Homologous Bone Marrow Transplantation Kidney Transplantation Hematopoietic Stem Cell Transplantation Heart Transplantation Stem Cell Transplantation Lung Transplantation Transplantation Conditioning Graft Survival Organ Transplantation Blood Transfusion, Autologous Graft Rejection Cell Transplantation Pancreas Transplantation Islets of Langerhans Transplantation Tissue Donors Transplantation Immunology Transplantation Treatment Outcome Transplantation Chimera Graft vs Host Disease Immunosuppressive Agents Peripheral Blood Stem Cell Transplantation Transplantation, Isogeneic Living Donors Transplantation, Heterotopic Cord Blood Stem Cell Transplantation Time Factors Heart-Lung Transplantation Retrospective Studies Combined Modality Therapy Recurrence Immunosuppression Transplantation Tolerance Tissue and Organ Procurement Histocompatibility Testing Whole-Body Irradiation Skin Transplantation Liver Failure Fetal Tissue Transplantation Postoperative Complications Mesenchymal Stem Cell Transplantation Hematologic Neoplasms Follow-Up Studies Melphalan Survival Analysis Transplantation, Heterologous Tissue Transplantation Survival Rate Cyclophosphamide Remission Induction Multiple Myeloma Waiting Lists Histocompatibility Corneal Transplantation Busulfan Cyclosporine T-Lymphocytes Tacrolimus Lymphoma, Non-Hodgkin Antineoplastic Combined Chemotherapy Protocols Bone Marrow Purging Cadaver HLA Antigens Disease-Free Survival Hematopoietic Stem Cells Hematopoietic Stem Cell Mobilization Leukemia Carmustine Brain Tissue Transplantation Myeloablative Agonists Liver Diseases Salvage Therapy Facial Transplantation Organ Preservation Antigens, CD34 Donor Selection Transplants Hodgkin Disease Cells, Cultured Prognosis Acute Disease Antilymphocyte Serum Etoposide Lymphocyte Culture Test, Mixed Risk Factors Tissue and Organ Harvesting Prospective Studies Leukemia, Myeloid, Acute Bone Marrow Cells Kidney Failure, Chronic Anemia, Aplastic Granulocyte Colony-Stimulating Factor Cytotoxicity, Immunologic Cell Differentiation Cytomegalovirus Infections Lymphocyte Activation Cytarabine

No FAQ available that match "transplantation with autologous hematopoietic"